The Multidisciplinary Approach to Patient Counseling and Care Transitions in Wilson Disease

In 'The Multidisciplinary Approach to Patient Counseling and Care Transitions in Wilson Disease,' our panel delves into the human elements of lifelong disease management. Dr. Peter Hedera emphasizes that clinicians can "never rest on their laurels," even with well-controlled patients, as adherence is a never-ending battle influenced by life stressors and "treatment burnout." He advocates for a tailored approach that uses objective laboratory evidence—such as shifting copper levels—to non-confrontationally re-engage patients who may be skipping doses.

Dr. Rima Fawaz highlights the high-risk period of transitioning from adolescent to adult care. She shares the Yale model’s success in creating a seamless transition through the Wilson Disease Registry, where patients often encounter the same core team across life stages. The discussion underscores that pediatric adherence is frequently driven by parents, but as patients enter young adulthood, the focus must shift to direct patient education regarding the specific mechanisms of their medication, such as why zinc must be taken away from food to remain effective.

The panel also explores the "team effort" required to maintain compliance, involving social workers, nutritionists, and medication access specialists who navigate insurance and prior authorizations. Dr. Hedera adds that health psychology and even visual aids—such as showing patients videos of their own prior symptoms—can be powerful tools for reinforcing the necessity of therapy without relying solely on fear. The experts conclude that a proactive, multidisciplinary system that tracks follow-up appointments and lab work is the most effective way to ensure long-term clinical success.

Our next episode, 'The Future of Wilson Disease Care: Expert Centers, Advocacy, and Clinical Hope,' further explores Wilson disease, highlighting the essential role of multidisciplinary collaboration and patient advocacy organizations. The experts discuss the clinical "one-stop-shop" model, the importance of referring to centers of excellence, and the optimistic future of treatment as research advances toward potentially curative genetic therapies.